pancreatic cancer glutathione enhancement

pancreatic cancer glutathione enhancement Targeting glutamine dependency confers vulnerability to GPX4-dependent ferroptosis: Cell Reports Medicine Novel drug therapy kills pancreatic

Name: pancreatic cancer glutathione enhancement Targeting glutamine dependency confers vulnerability to GPX4-dependent ferroptosis: Cell Reports Medicine Novel drug therapy kills pancreatic
Brand: southroadsurgery.com.au
SKU: 13347396143
Price: 23.37 USD
Availability: InStock
Rating: 4.8757 (5 reviews)

Novel drug therapy kills pancreatic cancer cells by reducing levels of antioxidants Cold Spring Harbor Laboratory Role of Glutathione in Cancer: From Mechanisms to Therapies PMC GOT2: New therapeutic target in pancreatic cancer ScienceDirect Beyond the tumor: Enhancing pancreatic cancer therapy through glutamine metabolism and innovative drug delivery Su 2025 Journal of Cell Communication and Signaling Wiley Online Library Glutathione Dependent Pathways in Cancer Cells Increased glucose availability sensitizes pancreatic cancer to chemotherapy bioRxiv

SKU: 13347396143 · From southroadsurgery.com.au

4.9

USD23.37 USD71.37

Pay in 4 interest-free payments of $5.84 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

In a first-in-human clinical trial (NCT02491281), LNA043 was administered via intra-articular injection before total knee replacement, and results showed that LNA043 could reverse the transcriptome signature associated with osteoarthritis by promoting the expression of hyaline cartilage matrix components and anabolic signaling pathways [435]